| Sunday, June 28Discussion Leader: Joe Konopelski, UC - Santa Cruz
William Roush  (University of Michigan)  -  Problems in Glycoside Chemistry:  Progress Towards the Synthesis of Aureolic Acid Antitumor Antibiotics
Vincent Rocco  (Eli Lilly)  Palladium-Mediated Cross Coupling Reactions in Heterocyclic Construction
 Monday, June 29Discussion Leader: Lou Jungheim, Eli Lilly
Discussion Leader: James Audia, Eli LillyPeter Jacobi  (Dartmouth University)  -  Synthesis and Study of Biologically Important Tetrapyrroles
John Macor  (Bristol Myers-Squibb)  -  A Tale of Two Receptors: Synthesis of Agonists for the Serotonergic and Cholinergic Families of Receptors
Edward Taylor  (Princeton University)  Multiple Inhibition of Folate-Dependent Enzymes--Discovery of an Exceptionally Promising Antitumor Agent
 
Duane Burnett  (Schering-Plough) -  Design and Synthesis of Biochemical Tools for the Investigation of the Mechanism of Action of the ß-Lactam Cholesterol Absorption Inhibitor, Sch 58235
Joachim Schantl, University of Innsbruck - Azomethine Imines in Four- and Five-Membered Rings: Stable Cyclic Valence Isomers of an alpha-(Phenyldiazenyl)ketocarbene
Steven Burke  (University of Wisconsin-Madison)  -  Conformational Engineering and Convergent Functionality: Applications to Synthetic Ionophores and Ion Channel Templates
 Tuesday, June 30Discussion Leader: Karen Romines, Pharmacia & Upjohn
Discussion Leader: Paul GFeldman, Glaxo-WellcomeShuji Kanemasa (Kyushu University)  -  Interaction of 1,3-Dipoles with a Lewis Acid - The Case of Diazo Compounds
Ronald Ratcliffe  (Merck)  -  Synthesis of a New Series of Carbapenem Antibiotics Active Against MRSA
Jacquelyn Gervay  (University of Arizona)  -  Synthesis and Structural Studies of Novel Carbohydrate-Based Heterocycles
 
Joel Hawkins  (Pfizer)  -  New Asymmetric Aldol and Ortho Boration Chemistry for a Drug Candidate
Stephen Bergmeier (Ohio State University) - Intramolecular Cyclization Reactions of Aziridine Allysilanes
Michael Martinelli (Eli Lilly) - Synthetic Studies on the Anti-Tumor Agent Cryptophycin 52 (LY355703)
 Wednesday, July 1Discussion Leader: Joachim Schantl, University of Innsbruck
Discussion Leader: Kenneth Doxsee, University of OregonMichelle Weidner-Wells  (R. W. Johnson Pharmaceutical Research Institute)  -  An Unexpected Reversal of Regioselectivity in the Dipolar Cycloaddition Reactions of Nitrile Oxides with Tertiary Cinnamides and Crotonamides
David Van Vranken  (University of California-Irvine)  -  Protein Aging: Clues for Organic Synthesis
Robert Batey (University of Toronto) - New Synthetic Approaches toward Pyrrolidine and Indolizidine Synthesis
Marco Ciufolini  (Université Claude Bernard, Lyon)  -  Synthetic Studies on Heterocyclic Natural Products
 
George Sheppard  (Abbott)   -  Synthetic Approaches to a Novel Series of MMP Inhibitors
Partha Ray (University of Memphis) - Synthesis and Antitumor Properties of Pyrimidoazepine-Based Tetrahydrofolic Acid Derivatives
Philip Kocienski  (University of Glasgow)  -  Synthesis of the Marine Antitumour Agents of the Pederin-Mycalamide Class
 Thursday, July 2Discussion Leader: Susan Tamura, Corvas
Discussion Leader: Dennis Hlasta, R.W. Johnson PRIRussell Dushin  (Wyeth-Ayerst)  -  A New Route to Enaminone Intermediates
Eric Edstrom  (University of Montana)  -  Chemistry of Indole-3-triflates
Harry Finch  (Glaxo-Wellcome)  -  A Natural Product Lead Into Strained [5,5]Bicyclic-trans-Lactones and -Lactams:  Total Synthesis and Potential Applications
 
James Cook  (University of Wisconsin-Milwaukee)  -  Enantiospecific Synthesis of Sarpajine and Ajmaline Alkaloids via the Asymmetric Pictet-Spengler Reaction
Joe Konopelski - Vice Chair's Remarks
 |